These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20708171)

  • 1. [Drug-eluting stents: do we respect the on-label use in our daily practice?].
    Puymirat E; Chaib A; Chaudeurge A; Trinquart L; Ledru F; Durand E; Danchin N; Blanchard D
    Ann Cardiol Angeiol (Paris); 2010 Aug; 59(4):196-204. PubMed ID: 20708171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of drug-eluting stents: impact of French recommendations on the rate of clinical restenosis at 2 years].
    Mboup MC; Moquet B; Zabalawi A; Delaunay R
    Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):88-92. PubMed ID: 22436635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome.
    Mahmoudi M; Delhaye C; Waksman R
    Cardiovasc Revasc Med; 2011; 12(6):385-90. PubMed ID: 21330220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective observational study of treatment practice patterns in acute coronary syndrome patients undergoing percutaneous coronary intervention in Europe.
    Ferrières J; Sartral M; Tcherny-Lessenot S; Belger M;
    Arch Cardiovasc Dis; 2011 Feb; 104(2):104-14. PubMed ID: 21402345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
    Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S
    Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
    Silber S; Richartz BM; Brilmayer M;
    Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries.
    Roe MT; Chen AY; Cannon CP; Rao S; Rumsfeld J; Magid DJ; Brindis R; Klein LW; Gibler WB; Ohman EM; Peterson ED;
    Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):414-20. PubMed ID: 20031871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual quality improvement in acute coronary syndromes: a performance improvement initiative.
    Cannon CP; Hoekstra JW; Larson DM; Mencia WA; Cornish J; Carter RD; Berry CA; Karcher RB
    Crit Pathw Cardiol; 2009 Mar; 8(1):43-8. PubMed ID: 19258838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study.
    Pelc-Nowicka A; Bryniarski L; Mirek-Bryniarska E; Zabojszcz M
    Kardiol Pol; 2009 Dec; 67(12):1335-41. PubMed ID: 20054764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.
    Paradis JM; Ducrocq G; Tanguay JF
    Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
    Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
    Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI.
    Zeymer U; James S; Berkenboom G; Mohacsi A; Iñiguez A; Coufal Z; Sartral M; Paget MA; Norrbacka K; Ferrieres J; Bakhai A;
    Eur J Prev Cardiol; 2013 Apr; 20(2):218-28. PubMed ID: 22345684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?
    Valgimigli M; Airoldi F; Zimarino M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10 Suppl 1():S17-26. PubMed ID: 19851216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.